An ‘uncoordinated’ immune response may explain why COVID-19 strikes some hard, particularly the elderly By Jon CohenSep. 16, 2020
The latest round in the CRISPR patent battle has an apparent victor, but the fight continues By Jon CohenSep. 11, 2020
Here’s how the U.S. could release a COVID-19 vaccine before the election—and why that scares some By Jon CohenAug. 28, 2020
In FDA’s green light for treating COVID-19 with plasma, critics see thin evidence—and politics By Kai Kupferschmidt, Jon CohenAug. 24, 2020
Russia’s approval of a COVID-19 vaccine is less than meets the press release By Jon CohenAug. 11, 2020
